New hope for head and neck cancer patients in experimental drug trial
NCT ID NCT06959082
Summary
This study is testing whether adding an experimental drug called VS-101 to standard chemoradiation treatment works better for adults with head and neck cancer. It will involve about 30 participants to see if the combination helps control the cancer longer and is safe. The main goal is to measure how many patients' tumors shrink or stop growing for at least 6 to 12 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center of Kansas
RECRUITINGWichita, Kansas, 67214, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health
RECRUITINGManhattan, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.